Robot-Assisted Bowel Cancer Screening Gains Traction in Australia

A cutting-edge robot developed in Australia, called Grace, has been hailed as a game-changer in bowel cancer screening. With an accuracy rate of 98%, Grace can process medical results up to eight times faster than traditional methods, detecting bleeding in the bowel at an earlier stage and reducing the need for colonoscopies. The robot's capabilities are being touted as a potential solution to the nation's bowel cancer problem, which claimed 5,000 lives in 2003 and diagnosed almost 13,000 new cases the same year.

Key Takeaways:

• Grace, an Australian-made robot, has been developed to process medical results up to eight times faster than conventional methods, with an accuracy rate of 98%.
• The robot can detect bleeding in the bowel at an earlier stage, reducing the need for colonoscopies.
• Tenders for a nationwide bowel cancer screening program, which is set to be launched later this year, are currently with the federal and NSW governments.
• Enterix, a company led by managing director Caroline Beasley, hopes to secure the contract for implementing the screening program using Grace.
• The robot can analyze three million cancer test results a year if it runs 24 hours a day, requiring eight or nine technicians working around the clock to achieve the same figure.
• Tests analyzed by Grace would cost $34, compared to a range of $27.60 to $160 for current testing.
• The Australian government is considering implementing a nationwide bowel cancer screening program using Grace.

Statistics:

• 5,000 Australians died from bowel cancer in 2003.
• Almost 13,000 new cases of bowel cancer were diagnosed in Australia in 2003.
• The robot Grace can analyze three million cancer test results a year if it runs 24 hours a day.
• It would take eight or nine technicians working around the clock to achieve the same figure.

Sources:

• Asia Pulse, Apr 21, 2023
• (AAP)